CA2389964A1 - Nouveau procede permettant de diagnostiquer, surveiller, determiner le stade, imager et traiter un cancer - Google Patents

Nouveau procede permettant de diagnostiquer, surveiller, determiner le stade, imager et traiter un cancer Download PDF

Info

Publication number
CA2389964A1
CA2389964A1 CA002389964A CA2389964A CA2389964A1 CA 2389964 A1 CA2389964 A1 CA 2389964A1 CA 002389964 A CA002389964 A CA 002389964A CA 2389964 A CA2389964 A CA 2389964A CA 2389964 A1 CA2389964 A1 CA 2389964A1
Authority
CA
Canada
Prior art keywords
lng108
cancer
patient
levels
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002389964A
Other languages
English (en)
Inventor
Herve Recipon
Roberto A. Macina
Sei-Yu Chen
Yongming Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2389964A1 publication Critical patent/CA2389964A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1054—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention se rapporte à de nouveaux procédés permettant de détecter, de diagnostiquer, de surveiller, de déterminer le stade, d'établir un pronostic, d'imager et de traiter un cancer.
CA002389964A 1999-11-04 2000-11-03 Nouveau procede permettant de diagnostiquer, surveiller, determiner le stade, imager et traiter un cancer Abandoned CA2389964A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16344499P 1999-11-04 1999-11-04
US60/163,444 1999-11-04
PCT/US2000/030482 WO2001032209A1 (fr) 1999-11-04 2000-11-03 Nouveau procede permettant de diagnostiquer, surveiller, determiner le stade, imager et traiter un cancer

Publications (1)

Publication Number Publication Date
CA2389964A1 true CA2389964A1 (fr) 2001-05-10

Family

ID=22590029

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002389964A Abandoned CA2389964A1 (fr) 1999-11-04 2000-11-03 Nouveau procede permettant de diagnostiquer, surveiller, determiner le stade, imager et traiter un cancer

Country Status (4)

Country Link
EP (1) EP1227841A4 (fr)
JP (2) JP3524536B2 (fr)
CA (1) CA2389964A1 (fr)
WO (1) WO2001032209A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
CN112365948B (zh) * 2020-10-27 2023-07-18 沈阳东软智能医疗科技研究院有限公司 癌症分期预测系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837498A (en) 1994-03-08 1998-11-17 Human Genome Scienes, Inc. Corpuscles of stannius protein, stanniocalcin
KR100432260B1 (ko) 1994-11-10 2004-09-16 휴먼 게놈 사이언시즈, 인코포레이티드 사람스탄니오칼신-알파활성을갖는폴리펩타이드및이를포함하는약제학적조성물
US5747264A (en) 1996-08-02 1998-05-05 Smithkline Beechum Corporation Method of diagnosing and monitoring prostate cancer

Also Published As

Publication number Publication date
JP2003513254A (ja) 2003-04-08
WO2001032209A1 (fr) 2001-05-10
JP3524536B2 (ja) 2004-05-10
EP1227841A1 (fr) 2002-08-07
JP2004170428A (ja) 2004-06-17
EP1227841A4 (fr) 2003-01-22

Similar Documents

Publication Publication Date Title
US7326529B2 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6730477B1 (en) Method of diagnosing, monitoring and staging breast cancer
EP1109937B1 (fr) PROCEDE DE DIAGNOSTIC, DE SURVEILLANCE, DE CLASSIFICATION PAR STADES et D'IMAGERIE DE DIVERS CANCERS
WO2000008210A1 (fr) Nouvelle methode permettant de diagnostiquer, de surveiller le cancer du sein, d'en determiner le stade ainsi que d'en former des images et de le traiter
WO2001037779A2 (fr) Nouvelle methode de diagnostic, de surveillance, de stadification, d'imagerie et de traitement du cancer du sein
CA2347656A1 (fr) Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons
US7326402B2 (en) Method of diagnosing, monitoring, staging, imaging and treating cancer
CA2389964A1 (fr) Nouveau procede permettant de diagnostiquer, surveiller, determiner le stade, imager et traiter un cancer
US20080107596A1 (en) Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Breast Cancer
WO2000020640A1 (fr) Nouveau procede pour diagnostiquer, surveiller, etablir la stadification, obtenir des images et traiter des cancers gastro-intestinaux
US6858386B1 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
US7014996B1 (en) Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
US20050106620A1 (en) Novel method of diagnosing, monitoring, staging, imaging and treating cancer
CA2416285A1 (fr) Procede de diagnostic, de controle, de determination du stade, d'imagerie, et de traitement du cancer du colon
CA2345285A1 (fr) Nouveau procede pour diagnostiquer, controler, etablir le bilan d'extension, visualiser, et traiter des cancers gynecologiques
CA2346326A1 (fr) Nouveau procede de diagnostic, de controle, de stadification, d'imagerie et de traitement de cancers gynecologiques ou de cancers de la prostate
WO2000012761A1 (fr) Nouvel anticorps permettant de diagnostiquer le cancer de la vessie

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued